Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
01/1997
01/07/1997US5591749 Imidazopyridines as serotonergic 5-HT3 -antagonists
01/07/1997US5591748 Immunomodulatory azaspiranes
01/01/1997CN1139122A Hydroxymethyl quenuclidine catalyst compositions for making polyurethane foams
12/1996
12/31/1996US5589477 Pyrimidine derivatives and drugs
12/25/1996CN1138850A Novel high enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-'beta'-amino acids
12/24/1996US5587479 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
12/19/1996WO1996040641A1 Sulfonamide derivatives as cell adhesion modulators
12/19/1996WO1996040100A1 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS
12/19/1996CA2223727A1 Arylsulfonylaminobenzene derivatives and the use thereof as factor xa inhibitors
12/18/1996CN1033584C Benzo-fused lactams that promote release of growth hormone
12/17/1996US5585357 Heteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitors
12/11/1996EP0747407A1 Hydroxymethyl quinuclidine catalyst compositions for making polyurethane foams
12/11/1996EP0747355A1 Novel carbamate derivative and medicinal composition containing the same
12/10/1996US5583140 Administering 2-azabicyclo(2.2.2)oct-5-ene derivatives to treat neurodegenerative disorders such as senile dementia of alzheimer's type
12/10/1996US5583134 1-azoniabicyclo[2.2.2] octanes and pharmaceutical compositions in which they are present
12/05/1996WO1996038430A1 Process for making heterocyclic compounds
12/05/1996CA2222033A1 Process for making heterocyclic compounds
12/04/1996EP0745602A1 Quinidine immunoassay and reagents
12/04/1996EP0745601A1 Process for preparing 1,2,5-thiadiazole derivatives
12/01/1996CA2176417A1 Quinidine immunoassay and reagents
11/1996
11/26/1996US5578602 Certain 1-azabicyclo[3.3.1]nonene derivatives and their pharmacological uses
11/26/1996US5578601 Nonpeptide bradykinin antagonists
11/21/1996WO1996036637A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
11/20/1996EP0743302A2 Sulfonamide fibrinogen receptor antagonists
11/19/1996US5576434 5-ht3 receptor antagonist
11/19/1996US5576323 Excitatory amino acid receptor antagonists
11/19/1996US5576317 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
11/19/1996CA2109613C Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
11/12/1996US5574043 Certain [1,2,5-thiadiazol-4-yl]-1-azabicyclo [3.2.1]octane derivatives and their pharmaceutical uses
11/07/1996WO1996034864A1 Piperazino derivatives as neurokinin antagonists
11/05/1996US5571918 Reacting 3-hydroxy-3-mercaptomethylquinuclidine and a carbonyl compound in the presence of a catalyst
10/1996
10/30/1996EP0739204A1 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
10/29/1996US5569662 Quinuclidine derivatives as substance P antagonists
10/29/1996US5569447 Stannylated 3-quinuclidinyl benzilates and methods of preparing radiohalogenated derivatives
10/24/1996WO1996033186A1 Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
10/24/1996WO1996033172A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
10/23/1996EP0738149A1 1-aminoindan derivatives and compositions thereof
10/22/1996US5567818 Reduction; separation; dehydration
10/17/1996WO1996032382A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/17/1996CA2220827A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/10/1996WO1996031498A1 Novel heterocyclic compounds
10/10/1996CA2217197A1 Novel heterocyclic compounds
10/09/1996EP0735869A1 A method of treating gastrointestinal motility disorders
10/09/1996CN1133044A Antipsychotic method
10/09/1996CN1132625A NK-1 receptor antagonits and 5HT3 receptor antagonists for treatment of emesis
10/08/1996US5563148 Specific 5-HT3 antagonists
10/03/1996WO1995027727A3 Process for peptide segment condensation
10/02/1996CN1132072A NK-1 receptor antagonists for treatment of neuronal injury and stroke
10/01/1996US5561149 For nasal administration
09/1996
09/24/1996US5559124 Depolarizing skeletal muscle relaxants
09/17/1996US5556860 Quinazolinone derivatives possessing calcium uptake inhibiting activity
09/17/1996US5556856 Anitarrhythmia, analgesics
09/17/1996US5556851 Treatment of nausea or emesis from anticancer drugs or x-ray treatment
09/10/1996US5554763 1-azoniabicyclo[2.2.1] heptanes and pharmaceutical compositions in which they are present
09/10/1996US5554753 Catalytic enantioselective synthesis of α-amino acid derivatives by phase-transfer catalysis
09/10/1996US5554627 Tachykinin antagonists
09/10/1996US5554613 Quinuclidine derivatives, qualene synthase inhibitors, treatment of hypercholesterolemia, atherosclerosis and fungus infections
09/06/1996WO1996026938A1 Novel quinuclidine derivatives having tricyclic fused hereto ring
09/06/1996CA2213706A1 Novel quinuclidine derivative having tricyclic hetereo condensed ring
09/04/1996EP0589924B1 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
09/03/1996US5552408 Benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
08/1996
08/28/1996EP0727993A1 (non descriptive)-a method for delaying hiv individual aids by administration of substituted azaspirane compounds
08/28/1996CN1129942A Aza spiro-compounds acting on the cholinergic system with muscarinic agonist activity
08/28/1996CN1129934A Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
08/27/1996US5550289 N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
08/22/1996WO1996025160A1 The use of heterocyclic compounds
08/20/1996US5547964 Antiemetic during drug therapy
08/14/1996CN1032534C Method for prepn. of diaminotrifluoromethylpyridine derivatives
08/13/1996US5545740 Nitrosation process
08/13/1996US5545412 Using lipophilic compounds to transfect dna and for drug delivery by forming complexes to penetrate cellular membranes
08/08/1996WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/06/1996US5543426 Use of certain 3,7-disubstituted indole compounds for treating depression or cognitive disorders
08/06/1996US5543419 Treating chronic obstructive airways disease or asthma; antimuscarinic bronchodilator agents
07/1996
07/31/1996EP0723959A1 Heterocyclic compounds as tachykinin receptor antagonists, process for their preparation and pharmaceuticals containing them
07/30/1996US5541194 Pharmaceutical compostion used to treat dementia
07/23/1996US5538982 Medical use for tachykinin antagonists
07/18/1996WO1996021644A1 Indole derivatives useful in the treatment of osteoporosis
07/18/1996CA2209936A1 Indole derivatives useful in the treatment of osteoporosis
07/17/1996EP0721778A2 NK-1 receptor antagonists for the treatment of neuronal injury and stroke
07/10/1996EP0720601A1 Gastrin and cck receptor ligands
07/09/1996US5534521 Serotonin antagonists
07/09/1996US5534520 Spiro compounds containing five-membered rings
07/04/1996WO1996020194A1 Novel quinuclidine derivatives and medicinal composition thereof
07/03/1996EP0719266A1 Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
06/1996
06/27/1996WO1996019474A1 Quinazolines as inhibitors of endothelin converting enzyme
06/27/1996WO1996019452A1 A process for the preparation of substituted 4-ethyl-piperidines and an intermediate for the preparation of same
06/27/1996CA2206046A1 Quinazolines as inhibitors of endothelin converting enzyme
06/26/1996EP0718297A1 Pyrazine derivatives as muscarinic receptor agonists
06/25/1996US5530118 Phospholipase inhibitor
06/22/1996CA2165751A1 Quinuclidine and azabicyclo¬2.2.1|heptane pyrazinyl ethers as muscarinic agonists
06/18/1996US5527813 Heterocyclic compounds and their preparation and use
06/18/1996US5527808 Fused tricyclic nitrogen containing heterocycles
06/13/1996WO1996017630A1 Substituted benzamides and radioligand analogs and methods of use
06/12/1996EP0716083A1 Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
06/12/1996EP0715855A2 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
06/05/1996EP0714880A1 Bis(methylidene)-phenylene-derivatives
06/05/1996EP0714394A1 Antipsychotic method
06/04/1996US5523299 Administering in treatment of psychotic disorders
05/1996
05/30/1996WO1996007410A3 Depolarizing skeletal muscle relaxants
05/23/1996WO1996014846A1 Dihydropyrimidines and uses thereof
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 58